Vitamin D, Exercise Combination Helps Geriatrics Maintain Muscle Mass, Function


In an intervention study, investigators try to show whether vitamin D deficiency interferes with slowing muscle wasting and losing function in geriatric adults.

While many older adults struggle with exercise, a physical activity regimen along with vitamin D supplementation could be beneficial.

A team, led by Neide AP Nascimento, division of geriatric and gerontology at the Federal University of São Paulo in Brazil, analyzed the data from 345 geriatric women at least 60 years old who regularly exercise at the Social Service of Commerce Santana, Community Center in order to learn the effect of 25(OH)D supplementation along with physical exercise in an interventional study.

There is substantial evidence that serum 25(OH)D concentrations greater than 25-30 nmol/L should be avoided for all age groups.

In general, a 25(OH)D level of less than 20 ng/mL has been associated with neuromuscular performance issues in elderly people including poor physical performance, low muscular strength, and muscle weakness, suggesting that vitamin D supplementation is beneficial for geriatric adults.

A vitamin D deficiency is linked to proximal myopathy observed by the atrophy of type II muscle fibers, which can have a negative effect on neuromuscular performance and can contribute to osteopenia and osteoporosis by increasing parathyroid hormone (PTH) concentrations and bone turnover.

Several epidemiological studies have analyzed lower extremity function by testing performance during long walks among older adults with lower vitamin D levels.

Physical exercises are highly effective in slowing down muscle wasting and the loss of function, but elderly patients find it difficult to exercise enough to prevent these changes. There has not been a previous study analyzing the relationship between 25(OH)D supplementation, different modalities of physical exercise, and its neuromuscular effects.

The study included 146 geriatric women in an aquatic training program, 99 elderly women in a multifunctional fitness program, and 100 community-dwelling elderly women who had not been exercising for the last year as a control group.

The participants were asked to discontinue the use of vitamin D supplements 2 months prior to the initiation of the supplementation protocol of the study.

Each group was administered 1 cholecalciferol bottle if the participant had 25(OH)D levels below the median level. They were also instructed to consume 21,000 IU per week—4 drops per week—of cholecalciferol for 12 months.

The investigators also administered a series of physical tests for the participants, including a timed up-and-go (TUG)test, a 2-min step (2-MST), a 30-second chair stand (CS), functional reach (FRT), unipedal balance test with visual control (UB), and a portable dynamometer for the strength of hip flexors (HS). They also measured the serum 25(OH)D and intact parathyroid hormone levels at the beginning and conclusion of the 12-month study.

They compared the treatments using a general linear model for repeated measures (P <.005).

“There was a significant increase in 25(OH)D levels in ATSG (P <.001), MFSG (P <.001), and CTSG (P < .001),” the authors wrote. “The relationship between 25(OH)D levels and physical exercise was significant in TUG (P =.005), UB (P =.03), HS (P <.001), CS (P =.04), and 2MST (P =.02).”

The study, “Effect of Vitamin D Level and Physical Exercise on the Physical Performance and Functional Test Results in Elderly Women,” was published online in the Journal of Geriatric Medicine and Gerontology.

Related Videos
Primary Care Roles in Alzheimer Diagnosis, with Theresa Sivers-Teixeira, MSPA, PA-C
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
What Should the American Academy of Physician Associates Focus on in 2025?
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
Etienne Sibille, PhD: Innovations in Cognitive Pathology
© 2024 MJH Life Sciences

All rights reserved.